Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
2005-08-23
2005-08-23
Bernhardt, Emily (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
C544S343000, C514S250000
Reexamination Certificate
active
06933387
ABSTRACT:
The present invention is directed to 1,2,3,4,10,10a-hexahydropyrazino [1,2-a]indole derivatives of formula (I):as well as pharmaceutically acceptable salts, hydrates and esters thereof, wherein the substituents have the meanings provided in the specification. Compounds of the present invention may be used in the treatment or prevention of obesity or Type II diabetes.
REFERENCES:
patent: 3317524 (1967-05-01), Freed et al.
patent: 5432177 (1995-07-01), Baker et al.
patent: 0572863 (1993-12-01), None
patent: WO 0035922 (2000-06-01), None
patent: WO 00/44753 (2003-08-01), None
Bentley Jonathan Mark
Hebeisen Paul
Muller Marc
Richter Hans
Roever Stephan
Bernhardt Emily
Hoffmann-La Roche Inc.
Johnston George W.
Megerdictchian Samuel H.
Tramaloni Dennis P.
LandOfFree
Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3459924